TY - THES A1 - Kutschera, Maren T1 - Interaktionen von Flavanolen mit der humanen intestinalen Mikrobiota Y1 - 2010 CY - Potsdam ER - TY - THES A1 - Gerber, Chimgee Baasanjav T1 - Detection and identification of genotoxicant from brassica plants Y1 - 2010 CY - Potsdam ER - TY - THES A1 - Henkel, Janin T1 - Modulation der Insulin-abhängigen Regulation des hepatischen Glucose- und Lipidmetabolismus durch Prostaglandin E2 Y1 - 2010 CY - Potsdam ER - TY - THES A1 - Hesse, Deike T1 - Die Rolle des trans-Goli-Proteins ARFRP1 für den Glucose- und Lipidmetabolismus in der Leber und im Fettgewebe der Maus Y1 - 2010 CY - Potsdam ER - TY - THES A1 - Blum, Claudia T1 - Biosynthese und Zielsteuerung von TAS2R-Bitterrezeptoren Y1 - 2010 CY - Potsdam ER - TY - JOUR A1 - Hocher, Berthold T1 - Adenosine A1 receptor antagonists in clinical research and development N2 - Selective adenosine A1 receptor antagonists targeting renal microcirculation are novel pharmacologic agents that are currently under development for the treatment of acute heart failure as well as for chronic heart failure. Despite several studies showing improvement of renal function and/or increased diuresis with adenosine A1 antagonists, particularly in chronic heart failure, these findings were not confirmed in a large phase III trial in acute heart failure patients. However, lessons can be learned from these and other studies, and there might still be a potential role for the clinical use of adenosine A1 antagonists. We review the role of adenosine A1 receptors in the regulation of renal function, and emerging data regarding the safety and efficacy of A1 adenosine receptor antagonists based on all available completed and reported clinical trials using A1 adenosine receptor antagonists. The majority of trials were done in heart failure patients. However, there is clear clinical evidence for a role of this new class in hepatorenal syndrome, hypotension on dialysis, and radiocontrast media-induced nephropathy. Y1 - 2010 UR - http://www.nature.com/ki/index.html U6 - https://doi.org/10.1038/Ki.2010.204 SN - 0085-2538 ER - TY - JOUR A1 - Henze, Andrea A1 - Frey, Simone K. A1 - Raila, Jens A1 - Scholze, Alexandra A1 - Spranger, Joachim A1 - Weickert, Martin O. A1 - Tepel, Martin A1 - Zidek, Walter A1 - Schweigert, Florian J. T1 - Alterations of retinol-binding protein 4 species in patients with different stages of chronic kidney disease and their relation to lipid parameters N2 - Retinol-binding protein 4 (RBP4) is elevated in patients with chronic kidney disease (CKD) and has been discussed as marker of kidney function. In addition to an elevated concentration, the existence of truncated RBP4 species, RBP4-L (truncated at last C-terminal leucine) and RBP4-LL (truncated at both C-terminal leucines), has been reported in serum of hemodialysis patients. Since little is known about the occurrence of RBP4 species during the progression of CKD it was the aim of this study to analyse this possible association. The presence of RBP4, RBP4-L, RBP4- LL and transthyretin (TTR) was assessed in serum of 45 healthy controls and 52 patients with stage 2-5 of CKD using ELISA and RBP4 immunoprecipitation with subsequent MALDI-TOF-MS analysis. A reduction of glomerular filtration rate was accompanied by a gradual elevation of RBP4 serum levels and relative amounts of RBP4-LL. Correlation analysis revealed a strong association of the RBP4-TTR ratio with parameters of lipid metabolism and with diabetes-related factors. In conclusion, RBP4 serum concentration and the appearance of RBP4-LL seem to be influenced by kidney function. Furthermore, the RBP4-TTR ratio may provide diagnostic potential with regard to metabolic complications in CKD patients. Y1 - 2010 UR - http://www.sciencedirect.com/science/journal/0006291X U6 - https://doi.org/10.1016/j.bbrc.2010.01.082 SN - 0006-291X ER - TY - JOUR A1 - Gerecke, Christian A1 - Schneider, Mandy A1 - Scholtka, Bettina T1 - Vimentin promoter methylation analysis is a suitable complement of a gene mutation marker panel for the detection of preneoplastic and neoplastic colonic lesions N2 - Abstracts: Strukturen veraendern - Heilung verbessern. 29. Deutscher Krebskongress. Berlin 24.-27. Februar 201 Y1 - 2010 UR - http://www.karger.com/onk U6 - https://doi.org/10.1159/000290860 SN - 0378-584X ER - TY - JOUR A1 - Fritzsche, Britta A1 - Schuchardt, Jan-Philipp A1 - Schmidt, Anja A1 - Nau, Heinz A1 - Schweigert, Florian J. A1 - Ruehl, Ralph T1 - CYP26A1-specific antagonist influence on embryonic implantation, gene expression and endogenous retinoid concentration in rats N2 - Retinoids are essential in vertebrate reproduction and embryonic development. All-trans-retinoic acid (ATRA) is tightly regulated during these processes. CYP26A1 is mainly responsible for its degradation. To study the role of CYP26A1 during implantation, we applied R115866, a CYP26A1-specific antagonist, to rats during early gestation days (GD). On GD 6.5 and 12 samples were collected and the number of embryos was evaluated. ATRA concentration increased in uterus and serum, mRNA expression of CYP26A1 and CRABP2 increased in the liver, but not in the uterus. Uterine COX1 and 17 beta HSD mRNA expression was decreased. The number of embryos on GD 12 was not altered in this setting. It can be concluded that uterine expression of the analyzed retinoid-response genes during early gestation is not altered by this R115866 treatment and instead indirectly via ATRA. From our experiment we cannot confirm that ATRA obtains a major influencing role in the regulation of embryonic implantation. Y1 - 2010 UR - http://www.sciencedirect.com/science/journal/08906238 U6 - https://doi.org/10.1016/j.reprotox.2010.05.005 SN - 0890-6238 ER - TY - JOUR A1 - Foeller, Michael A1 - Mahmud, Hasan A1 - Qadri, Syed M. A1 - Gu, Shuchen A1 - Braun, Manuel A1 - Bobbala, Diwakar A1 - Hocher, Berthold A1 - Lang, Florian T1 - Endothelin B receptor stimulation inhibits suicidal erythrocyte death N2 - Endothelins (ETs), potent endothelium-derived mediators, stimulate formation of nitric oxide, which, in turn, protects against suicidal erythrocyte death or eryptosis, characterized by phosphatidylserine exposure at the erythrocyte surface and triggered by increase in cytosolic Ca2+ ([Ca2+](i)). The present study explored whether the ET1- receptor ETB influences suicidal erythrocyte death. To this end, [Ca2+](i) (Fluo3-fluorescence) and phosphatidylserine exposure (annexin V-binding) were determined utilizing FACS analysis. Energy depletion increased [Ca2+]i and phosphatidylserine-exposure, effects significantly blunted by ET1 (IC50 approximate to 100 nM) and the ETB receptor- agonist sarafotoxin 6c (IC50 approximate to 10 nM) but not by ET2 and ET3. ET1 and sarafotoxin significantly delayed the kinetics of suicidal erythrocyte death following energy depletion. ETB stimulation did not blunt the effect of Ca2+- ionophore ionomycin (1 mu M) on phosphatidylserine exposure. The in vivo significance was tested using rescued ETB- knockout (etb(-/-)) and wild-type (etb(+/+)) mice. The number of phosphatidylserine-exposing erythrocytes, of reticulocytes and spleen size were significantly larger in etb(-/-) mice than in etb(+/+)-mice. The etb(-/-) erythrocytes were more susceptible to the eryptotic effect of oxidative stress and more rapidly cleared from circulating blood than etb(+/+) erythrocytes. Finally, the spleens from etb(-/-) mice were enlarged and contained markedly more phosphatidylserine- exposing erythrocytes than spleens from etb(+/+) mice. The observations disclose a novel function of ET1, i. e., protection from suicidal erythrocyte death. Y1 - 2010 UR - http://www.fasebj.org/ U6 - https://doi.org/10.1096/Fj.10-159483 SN - 0892-6638 ER -